Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
MW Weiner, DP Veitch, PS Aisen, LA Beckett… - Alzheimer's & …, 2017 - Elsevier
Abstract Introduction The Alzheimer's Disease Neuroimaging Initiative (ADNI) has continued
development and standardization of methodologies for biomarkers and has provided an …
development and standardization of methodologies for biomarkers and has provided an …
The Alzheimer's disease neuroimaging initiative 2 PET core: 2015
Introduction This article reviews the work done in the Alzheimer's Disease Neuroimaging
Initiative positron emission tomography (ADNI PET) core over the past 5 years, largely …
Initiative positron emission tomography (ADNI PET) core over the past 5 years, largely …
Morphological changes in subregions of hippocampus and amygdala in major depressive disorder patients
Despite many neuroimaging studies in the past years, the neuroanatomical substrates of
major depressive disorder (MDD) subcortical structures are still not well understood. Since …
major depressive disorder (MDD) subcortical structures are still not well understood. Since …
Influence of APOE genotype on hippocampal atrophy over time-an N= 1925 surface-based ADNI study
The apolipoprotein E (APOE) e4 genotype is a powerful risk factor for late-onset Alzheimer's
disease (AD). In the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, we …
disease (AD). In the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, we …
Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects
Apolipoprotein E (APOE) e4 is the major genetic risk factor for late-onset Alzheimer's
disease (AD). The dose-dependent impact of this allele on hippocampal volumes has been …
disease (AD). The dose-dependent impact of this allele on hippocampal volumes has been …
A novel pipeline leveraging surface-based features of small subcortical structures to classify individuals with autism spectrum disorder
Autism spectrum disorder (ASD) is accompanied with widespread impairment in social-
emotional functioning. Classification of ASD using sensitive morphological features derived …
emotional functioning. Classification of ASD using sensitive morphological features derived …
Systematic and comprehensive automated ventricle segmentation on ventricle images of the elderly patients: a retrospective study
Background and Objective: Ventricle volume is closely related to hydrocephalus, brain
atrophy, Alzheimer's, Parkinson's syndrome, and other diseases. To accurately measure the …
atrophy, Alzheimer's, Parkinson's syndrome, and other diseases. To accurately measure the …
Fine‐grained features characterize hippocampal and amygdaloid change pattern in Parkinson's disease and discriminate cognitive‐deficit subtype
L Zhang, P Zhang, Q Dong, Z Zhao… - CNS Neuroscience …, 2024 - Wiley Online Library
Aims To extract vertex‐wise features of the hippocampus and amygdala in Parkinson's
disease (PD) with mild cognitive impairment (MCI) and normal cognition (NC) and further …
disease (PD) with mild cognitive impairment (MCI) and normal cognition (NC) and further …
Predicting brain amyloid using multivariate morphometry statistics, sparse coding, and correntropy: validation in 1,101 individuals from the ADNI and OASIS databases
Biomarker assisted preclinical/early detection and intervention in Alzheimer's disease (AD)
may be the key to therapeutic breakthroughs. One of the presymptomatic hallmarks of AD is …
may be the key to therapeutic breakthroughs. One of the presymptomatic hallmarks of AD is …
Classification of Alzheimer's disease based on hippocampal multivariate morphometry statistics
Background Alzheimer's disease (AD) is a neurodegenerative disease characterized by
progressive cognitive decline, and mild cognitive impairment (MCI) is associated with a high …
progressive cognitive decline, and mild cognitive impairment (MCI) is associated with a high …